ArticleTranslational cancer research2022
The feasibility of MRI texture analysis in distinguishing glioblastoma, anaplastic astrocytoma and anaplastic oligodendroglioma.
Article in Translational cancer research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- APTw CEST MRI in therapy-naive IDH-wildtype glioblastoma: insights into tumor heterogeneity and molecular subtypes.Journal of neuro-oncology · 2026Article
- Review
- From Data to Decision: Integrating Bioinformatics into Glioma Patient Stratification and Immunotherapy Selection.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The aim of this study was to investigate whether texture analysis-based machine learning could be utilized in presurgical differentiation of high-grade gliomas in adults. Methods: This is a single-center retrospective study involving 150 patients diagnosed with glioblastoma (GBM) (n=50), anaplastic astrocytoma (AA) (n=50) or anaplastic oligodendroglioma (AO) (n=50). The training group and validation group were randomly divided with a 4:1 ratio. Forty texture features were extracted from contrast-enhanced T1-weighted images using LIFEx software. Two feature-selection methods were separately introduced to select optimal features, including distance correlation (DC) and least absolute shrinkage and selection operator (LASSO). Optimal features selected were fed into linear discriminant analysis (LDA) classifier and support vector machine (SVM) classifier to establish multiple classification models. The performance was evaluated by using the accuracy, Kappa value and area under receiver operating characteristic curve (AUC) of each model. Results: The overall diagnostic accuracies of LDA-based models were 76.0% (DC + LDA) and 74.3% (LASSO + LDA) in the validation group, while for SVM-based models were 58.0% (DC + SVM) and 63.3% (LASSO + SVM). The combination of DC and LDA reach the highest diagnostic accuracy, AUC of GBM, AA and AO were 0.999, 0.834 and 0.865 separately, indicating that this model could distinguish GBM from AA and AO commendably, whereas the differentiation between AA and AO was relatively difficult. Conclusions: This study indicated that MRI texture analysis combined with LDA algorithm has the potential to be utilized in distinguishing the subtypes of high-grade gliomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.